2020
DOI: 10.3390/nano10091857
|View full text |Cite
|
Sign up to set email alerts
|

Patchy Core/Shell, Magnetite/Silver Nanoparticles via Green and Facile Synthesis: Routes to Assure Biocompatibility

Abstract: Nanomedicine is entering a high maturity stage and is ready to reach full translation into the clinical practice. This is because of the ample spectrum of applications enabled by a large arsenal of nanostructured materials. In particular, bimetallic patchy core/shell nanoparticles offer tunable surfaces that allow multifunctional responses. Despite their attractiveness, major challenges regarding the environmental impact and biocompatibility of the obtained materials are yet to be solved. Here, we developed a … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
11
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5
1
1

Relationship

3
4

Authors

Journals

citations
Cited by 14 publications
(13 citation statements)
references
References 56 publications
2
11
0
Order By: Relevance
“…Another study evaluated magnetite/silver nanoparticles biocompatibility in Vero cells (Kidney epithelial cells). The results evidenced low cytotoxicity, hemolytic, and platelet aggregation tendency, which confirm a high biocompatibility 54 . Moreover, a cytotoxicity study of iron-silver core–shell nanoparticles (FeO/AgNPs) was carried out on Vero cell line, and the results showed that these nanoparticles were biocompatible up to 500 µgml −1 concentration.…”
Section: Resultssupporting
confidence: 54%
“…Another study evaluated magnetite/silver nanoparticles biocompatibility in Vero cells (Kidney epithelial cells). The results evidenced low cytotoxicity, hemolytic, and platelet aggregation tendency, which confirm a high biocompatibility 54 . Moreover, a cytotoxicity study of iron-silver core–shell nanoparticles (FeO/AgNPs) was carried out on Vero cell line, and the results showed that these nanoparticles were biocompatible up to 500 µgml −1 concentration.…”
Section: Resultssupporting
confidence: 54%
“…An appealing approach is to combine both translocating agents and nanomaterials. In this regard, we have developed novel nanobioconjugates by interfacing magnetite with cell-penetrating proteins and peptides [8][9][10][11][12][13].When developing nanocarriers for endosomal escape, an important obstacle is the limited availability of analytical methods to quantitatively measure the escape efficiency while detecting the endosomal pathways involved. One strategy consists of labeling the nanocarriers with fluorescent molecules to estimate their colocalization with endosomes via confocal imaging [7].…”
Section: Introductionmentioning
confidence: 99%
“…Type B gelatin was used due to its low price, biodegradability, and biocompatibility. Simultaneously, chitosan has antibacterial and mucoadhesive properties, plus the different molecular weights can potentially lead to favor different routes of intracellular trafficking and endosomal escape [7,8]. The NPs' synthesis and functionalization were corroborated via Fourier-transform infrared spectroscopy (FTIR).…”
Section: Introductionmentioning
confidence: 99%
“…Magnetite/silver NPs showed negligible hemolysis 1% at concentration up to 200 μg mL −1 while increase in hemolysis was observed with increase in concentration. 75 Another type of Ag–Pd NPs were also found biocompatible with RBCs up to its maximum dose of 200 μg mL −1 . 76 Our BNPs are also safe for human use as an alternate drug since 5% hemolysis is acceptable for biomaterials.…”
Section: Resultsmentioning
confidence: 99%